The Board denied the appellant's eligibility for direct payment of attorney fees from past due benefits awarded in a November 2023 rating decision granting service connection for prostate cancer residuals.
The deciding factor: The August 2023 claim seeking service connection for prostate cancer was not considered a 'supplemental' claim, as there was no prior claim to supplement, and the November 2023 rating decision was an initial decision on an original claim for benefits.
- Claimed conditions
- prostate cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 22, 2025
- Citation
- A25036841
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted a 40 percent evaluation for prostate cancer residuals from January 29, 2014 to August 12, 2021.
- Denied
The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities, including prostate cancer residuals, hearing loss, tinnitus, and erectile dysfunction.
- Dismissed
The appeal of a proposal to reduce the rating for service-connected prostate cancer residuals from 100 percent to 40 percent is dismissed as it was not a final decision.
- Granted
The Veteran's prostate cancer residuals are granted a 60 percent rating from July 7, 2023.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.